CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Millions, $ in Millions	Total	Number of shares of common stock	Common stock and additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023		535.4
Beginning balance at Dec. 31, 2023	$ 6,232		$ 33,070	$ (26,549)	$ (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(113)			(113)
Other comprehensive loss, net of taxes	99				99
Dividends declared on common stock	(1,208)			(1,208)
Issuance of common stock in connection with equity award programs (in shares)		1.0
Issuance of common stock in connection with equity award programs	34		34
Stock-based compensation expense	103		103
Tax impact related to employee stock-based compensation expense	(125)		(125)
Ending balance (in shares) at Mar. 31, 2024		536.4
Ending balance at Mar. 31, 2024	$ 5,022		33,082	(27,870)	(190)
Beginning balance (in shares) at Dec. 31, 2024	536.9	536.9
Beginning balance at Dec. 31, 2024	$ 5,877		33,533	(27,590)	(66)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,730			1,730
Other comprehensive loss, net of taxes	(165)				(165)
Dividends declared on common stock	(1,280)			(1,280)
Issuance of common stock in connection with equity award programs (in shares)		0.8
Issuance of common stock in connection with equity award programs	42		42
Stock-based compensation expense	85		85
Tax impact related to employee stock-based compensation expense	$ (82)		(82)
Ending balance (in shares) at Mar. 31, 2025	537.7	537.7
Ending balance at Mar. 31, 2025	$ 6,207		$ 33,578	$ (27,140)	$ (231)